Improved cure rates in pulmonary tuberculosis category II (retreatment) with mycobacterium w.
J Indian Med Assoc
;
2003 Nov; 101(11): 680, 682
Artigo
em Inglês
| IMSEAR
| ID: sea-96554
ABSTRACT
A controlled study to improve sputum conversion rate of current short course chemotherapy using immunomodulator containing mycobacterium w had been shown earlier. The same randomised study was continued further till the end of therapy. At the end of the intensive phase, sputum conversion rate in category II was 75.51% in mycobacterium w (MW) group as compared to 51.85% in the control group. The cure rate in category II was 97.96% and 77.77% in MW and control groups, respectively. Treatment failure in category 11 was 2.04% and 22.22% in MW and control groups respectively. The therapy was well tolerated.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Escarro
/
Tuberculose Pulmonar
/
Humanos
/
Vacinas Bacterianas
/
Adjuvantes Imunológicos
/
Resultado do Tratamento
/
Retratamento
/
Quimioterapia Combinada
/
Imunoterapia
/
Mycobacterium bovis
Tipo de estudo:
Ensaio Clínico Controlado
Idioma:
Inglês
Revista:
J Indian Med Assoc
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS